AbbVie (ABBV) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist

209.030
+4.010+1.96%

Close Feb 28 16:00 ET

209.310
+0.280+0.13%

Post 20:01 ET

369.01BMarket Cap87.46P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top AbbVie Executive Sells Millions in Stock!
TipRanksFeb 28 21:12 ET
Express News | Form 144 | AbbVie(ABBV.US) Officer Proposes to Sell 18.96 Million in Common Stocks
Moomoo NewsFeb 28 17:38 ET
AbbVie(ABBV.US) Officer Sells US$6.07 Million in Common Stock
Moomoo NewsFeb 28 17:01 ET
Wall Street Today: Market Ends Wild Political TV Day in the Green
Kevin TraversFeb 28 15:38 ET
AbbVie's Next Big Moneymaker? This Drug Just Took a Huge Step Toward Approval
Yahoo FinanceFeb 28 14:32 ET
NYSE New 52-Week Highs And Lows
Dow JonesFeb 28 12:21 ET

Comments

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

$AbbVie (ABBV.US)$
Could AbbVie's RINVOQ Become the First Oral Advanced Therapy for Giant Cell Arteritis in Europe?

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

PMAX is up 60% post-market 😱

Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training

$AbbVie (ABBV.US)$
Major Aesthetics Training Expansion: Allergan Unveils 3 Advanced Medical Centers Reshaping Provider Education

Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

$AbbVie (ABBV.US)$
FDA Approval: AbbVie's Groundbreaking Antibiotic Targets Drug-Resistant Infections

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

$AbbVie (ABBV.US)$ 200

1

1

Read more